|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Erasmus Medical Center |
|---|---|
| Information provided by: | Erasmus Medical Center |
| ClinicalTrials.gov Identifier: | NCT00529672 |
Purpose
For more than 100 years, surgery has been the standard of care of varicose veins of the legs. The down side of surgery is that it requires anesthesia, leaves scars, and has a relatively high recurrence rate in the long term (up to 40%). In the last decade, several new techniques have become available but they have not yet been compared to surgery. This trail will evaluate the effectiveness, patients` perspective and cost effectiveness of surgery and non-invasive techniques such as ultrasound guided sclerocompression therapy and endovenous laser therapy.
| Condition | Intervention | Phase |
|---|---|---|
|
Varicose Vein |
Procedure: crossectomie and short stripping Procedure: ultrasound guided sclerocompression therapy Procedure: endovenous laser therapy |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study |
| Official Title: | Randomized Unicenter Comparative Study of the Treatment of Insufficient Greater Saphenous Vein: Surgery vs Ultrasound Guided Sclerocompression Therapy With Foam and Endovenous Laser Therapy |
| Estimated Enrollment: | 240 |
| Study Start Date: | May 2007 |
| Estimated Study Completion Date: | May 2011 |
| Arms | Assigned Interventions |
|---|---|
|
1: Active Comparator
Surgery: crossectomie plus short stripping
|
Procedure: crossectomie and short stripping
under spinal or complete anaesthesia
|
|
2: Active Comparator
ultrasound guided sclerocompression therapy with foam (3% polidaconal)
|
Procedure: ultrasound guided sclerocompression therapy
1 part 3% polidocanol mixed with 3 parts of air. Between 3cc - 12 cc per varicose vein>
|
|
3: Active Comparator
Endovenous laser therapy (940 nm, about 70 J/cm)
|
Procedure: endovenous laser therapy
940 nm Diode laser. About 70 J/cm will be administered. Disposables from Angiocare will be used.
|
Hide Detailed DescriptionInclusion criteria:
Exclusion criteria:
Primary outcomes:
1. anatomical succes using US (absence of GSV or flow) (at 3 months, 1 and 5 year)
Secondary outcomes:
Included patients: total of 240 (80 per arm)
Study start: May 2007 (recruitment ongoing) Study completion: May 2011
Follow up after 3 months, 1, 2, 3, 4 and 5 years
Location: departmnent of dermatology, Erasmus MC, Rotterdam, The Netherlands
Principle investigators: M. Kockaert, T. Nijsten & M. Neumann
Publications:
Rasmussen LH, Bjoern L, Lawaetz M, Blemings A, Lawaetz B, Eklof B. Randomized trial comparing endovenous laser ablation of the great saphenous vein with high ligation and stripping in patients with varicose veins: short-term results. J Vasc Surg. 2007 Aug;46(2):308-15. Epub 2007 Jun 27.
Sharif MA, Lau LL, Lee B, Hannon RJ, Soong CV. Role of endovenous laser treatment in the management of chronic venous insufficiency. Ann Vasc Surg. 2007 Sep;21(5):551-5.
Mundy L, Merlin TL, Fitridge RA, Hiller JE. Systematic review of endovenous laser treatment for varicose veins. Br J Surg. 2005 Oct;92(10):1189-94.
Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C.Systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007 Aug;94(8):925-36.
Subramonia S, Lees TA.The treatment of varicose veins.Ann R Coll Surg Engl. 2007 Mar;89(2):96-100.
Bohler K. Varicose veins: disfigurement or disease? Herz. 2007 Feb;32(1):18-25.
Bamigboye AA, Smyth R. Interventions for varicose veins and leg oedema in pregnancy. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001066.
van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. New endovenous therapies of truncal varicosities are more effective than surgical stripping and sclerotherapy: meta-analysis and meta-regression. Lancet, Submitted
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Michael Kockaert, MD | 31 10 4634580 | M.KOCKAERT@ERASMUSMC.NL |
| Contact: Tamar Nijsten, MD, PhD | 31 10 4631019 | t.nijsten@erasmusmc.nl |
| Netherlands | |
| Erasmus MC dermatology | Recruiting |
| Rotterdam, Netherlands, 3000 CA | |
| Contact: Michael Kockaert, MD 31 10 4634580 m.kockaert@erasmusmc.nl | |
| Contact: Tamar Nijsten, MD, PhD 31 10 4631019 t.nijsten@ersmusmc.nl | |
| Sub-Investigator: Prof. sambeek, MD, PhD | |
| Principal Investigator: | Martino Neumann, MD, PhD | Erasmus MC |
More Information
| Study ID Numbers: | 2005-325 |
| Study First Received: | September 13, 2007 |
| Last Updated: | September 17, 2007 |
| ClinicalTrials.gov Identifier: | NCT00529672 History of Changes |
| Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
|
endovenous laser thearpy sclerocompression therapy crossectomie and stripping |
surgery treatment varicose veins |
|
Varicose Veins Vascular Diseases Cardiovascular Diseases |